Article Details

WuXi Biologics to acquire CMAB Biopharma Group

Retrieved on: 2021-03-18 03:45:00

Tags for this article:

Click the tags to see associated articles and topics

WuXi Biologics to acquire CMAB Biopharma Group. View article details on hiswai:

Excerpt

... and other companies including Ming Bioventures under which WuXi Bio will acquire over 90 per cent interest of CMAB Biopharma Group (CMAB).

Article found on: www.expresspharma.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up